Skip to content
MedsAcross

Medicine

Estrace 0.01% vaginal cream

Estradiol · Vaginal · Allergan
Available on requestPrescription onlyUS FDA

Estrace 0.01% vaginal cream is a prescription medicine containing Estradiol for vaginal use, marketed by Allergan, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at room temperature 20° to 25°C (59° to 77°F). Protect from temperatures…

Key facts

Active ingredient (INN)
Estradiol
Brand
Estrace
Strength
0.01%
Dosage form
Vaginal cream
Route
Vaginal
Packs
36 cartons, 1 tube
Marketing authorisation holder
Allergan
Manufacturers
AllerganA-S Medication Solutions
Origin register
US FDA, United States
Storage
Store at room temperature 20° to 25°C (59° to 77°F). Protect from temperatures in excess of 40° C (104° F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
G03CA03 Estradiol
HS code (indicative)
3004.39Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 July 2001
Identifiers
RxCUI 310169, 890918DailyMed set ID da52a602-f2a2-4382-be07-30351c58cc4b, dfc41fcd-c5ba-4b25-b647-cf04d3988b3eNDC 50090-2321, 0430-3754Application ANDA086069

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
36 carton in 1 case / 1 tube, with applicator in 1 carton / 42.5 g in 1 tube, with applicator0430-3754-14Allergan1 July 2001
1 tube in 1 carton / 42.5 g in 1 tube50090-2321-0A-S Medication Solutions2 March 2016

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 10 September 1986Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Estradiol 0.01% vaginal cream.

Compare all 5

Other strengths and forms of Estradiol

Clinical summary

Estradiol is an estrogen indicated for climara is an estrogen indicated for, among other approved uses. It is available as transdermal patches, tablets and gel for oral and topical use. MedsAcross supplies Estradiol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Estradiol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Estrace 0.01% vaginal cream for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.